As we begin our 30th anniversary year, we’re reflecting on what’s been possible through partnership with advocates like you and sharing some of the progress we’ve made together. In this newsletter, you’ll find updates on our recent work and a preview of what’s ahead. Here’s what you can read more about in this newsletter: What’s…
Friends had an exciting year filled with new projects, impactful collaborations, and continued progress toward advancing innovative cancer research. A heartfelt thank you to our advocate community for your time, insight, and partnership in 2025. Your voices and contributions continue to strengthen our shared mission to advance science, policy, and patient access. We look forward…
In this quarter’s issue, we are excited to share updates on some of the innovative work happening at Friends, including our latest efforts in advancing AI in oncology, upcoming events, and important developments in cancer research. What’s Happening at Friends?: Dive into our ai.RECIST Project, a cutting-edge initiative exploring the use of artificial intelligence (AI) for tumor…
In this quarter’s issue, we are excited to share highlights from our latest public meeting and advocate webinar, along with other important developments we’ve been monitoring in oncology. What’s Happening at Friends?: Catch up on highlights from our recent public meeting and watch our advocate webinar, where experts and advocates discussed groundbreaking work in cellular gene…
The year is off to an eventful start, and we’re excited to share what we’ve been working on. Here’s what you can read more about in this newsletter: What’s Happening at Friends?: Catch up on the highlights from our recent advocate-focused webinar, where a diverse panel of experts including voices from advocacy, research, and policy discussed the…
Friends of Cancer Research (Friends) had an eventful year of new projects launched, data insights shared at public meetings and in publications, and partnerships formed. For the final 2024 edition of the advocate newsletter, we’re sharing three advocate’s perspectives on our Annual Meeting topics and reflecting on progress made this year. We look forward to…
Welcome to Friends’ third Quarterly Advocacy Newsletter of 2024. In Q3, Friends published several peer-reviewed manuscripts with insights on enhancing representation in clinical trials, use of RWD to assess response to treatment, and opportunities for pragmatic elements to be incorporated in clinical trials supporting regulatory decisions. We’re excited to share details on these publications and…
Welcome to Friends’ second Quarterly Advocacy Newsletter of 2024. In Q2, Friends co-hosted a public meeting about cell therapies with the Parker Institute for Cancer Immunotherapy, published several peer-reviewed manuscripts, and launched a webpage for patients and advocates, including a section about our Advisory Advocates. We’re so excited to share these and other happenings at…
Welcome to Friends’ first Quarterly Patient Advocate Newsletter of 2024. 2023 Advocacy Newsletters Newsletter Feedback Form Here’s what you can read more about in this newsletter: What’s Happening at Friends?: Read about Friends’ research to ensure diagnostic tests consistently provide reliable results for patients and providers. Mark Your Calendars: Upcoming events, including public meetings hosted…
Dear Advocates, We are excited to welcome you to the fourth edition of the Friends Advocacy Newsletter. It has been a great year working with you to create and launch this resource and we want to hear your thoughts on what you have liked, what could be improved, and what you want to see more of. We…
